Language
English
Publication Date
1-1-2025
Journal
Frontiers in Immunology
DOI
10.3389/fimmu.2025.1618404
PMID
40808942
PMCID
PMC12343627
PubMedCentral® Posted Date
7-30-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Introduction: Clinical studies of T cells engineered with chimeric antigen receptor (CAR) targeting CD19 in B-cell malignancies have demonstrated that relapse due to target antigen (CD19) loss or limited CAR T cell persistence is a common occurrence. The possibility of such events is greater in solid tumors, which typically display more heterogeneous antigen expression patterns and are known to directly suppress effector cell proliferation and persistence. T cell engineering strategies to overcome these barriers are being explored. However, strategies to simultaneously address both antigen heterogeneity and T cell longevity, while localizing anti-tumor effects at disease sites, remain limited.
Methods: In this study we explore a dual antigen targeting strategy by directing independent CARs against the solid tumor targets PSCA and MUC1. To enhance functional persistence in a tumor-localized manner, we expressed the transgenic IL-7 cytokine and receptor (IL-7Rα) in respective CAR products.
Results: This binary strategy, which incorporates dual antigen targeting with transgenic cytokine support, resulted in enhanced potency, T cell expansion, and durable antitumor effects in a pancreatic tumor model compared to single antigen targeting or dual antigen targeting in absence of the transgenic cytokine support.
Discussion: The transgenic IL-7 armed binary CAR T cell approach could improve the efficacy of CAR-based therapies for solid tumors.
Keywords
Animals, Immunotherapy, Adoptive, Humans, Receptors, Chimeric Antigen, Interleukin-7, Mice, T-Lymphocytes, Mucin-1, Cell Line, Tumor, Antigens, Neoplasm, Pancreatic Neoplasms, Receptors, Antigen, T-Cell, Xenograft Model Antitumor Assays, Receptors, Interleukin-7, Female, Neoplasm Proteins, chimeric antigen receptor, T-cell therapy, IL-7, IL-7R, solid tumor, pancreatic cancer, PSCA, MUC 1
Published Open-Access
yes
Recommended Citation
Torres Chavez, Alejandro G; McKenna, Mary K; Gupta, Anmol; et al., "Il-7 Armed Binary Car T Cell Strategy to Augment Potency Against Solid Tumors" (2025). Faculty, Staff and Students Publications. 8851.
https://digitalcommons.library.tmc.edu/baylor_docs/8851